Mount Sinai Study Uncovers Why Certain Myeloma Patients Remain Cancer-Free Long After CAR T Therapy
In a groundbreaking advancement in the treatment of multiple myeloma, researchers at the Icahn School of Medicine at Mount Sinai have unveiled critical insights into...
















